InspireMD Inc (NSPR) - Product Pipeline Analysis, 2018 Update

  • ID: 4372875
  • Company Profile
  • 34 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Bioiasis AD Sofia
  • Etropal Ad
  • InterCure Ltd
  • MORE
InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction, and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InspireMD Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bioiasis AD Sofia
  • Etropal Ad
  • InterCure Ltd
  • MORE
  • InspireMD Inc Company Overview
  • InspireMD Inc Company Snapshot
  • InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
  • InspireMD Inc - Pipeline Analysis Overview
  • InspireMD Inc - Key Facts
  • InspireMD Inc - Major Products and Services
  • InspireMD Inc Pipeline Products by Development Stage
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
  • InspireMD Inc Pipeline Products Overview
  • CGuard Embolic Prevention System
  • CGuard Embolic Prevention System Product Overview
  • CGuard Embolic Prevention System Clinical Trial
  • MGuard Drug Eluting Stent
  • MGuard Drug Eluting Stent Product Overview
  • MGuard Prime EPS
  • MGuard Prime EPS Product Overview
  • MGuard Prime EPS Clinical Trial
  • Next Gen CGuard - 5F
  • Next Gen CGuard - 5F Product Overview
  • NGuard Neurovascular
  • NGuard Neurovascular Product Overview
  • PVGuard Peripheral
  • PVGuard Peripheral Product Overview
  • RGuard Renal
  • RGuard Renal Product Overview
  • InspireMD Inc - Key Competitors
  • InspireMD Inc - Key Employees
  • InspireMD Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • InspireMD Inc, Recent Developments
  • Apr 30, 2018: InspireMD Announces Regulatory Approval and Reimbursement to Commercialize both CGuard EPS and MGuard Prime Products in Vietnam
  • Apr 19, 2018: InspireMD’s CGuard Embolic Prevention System to be Featured at ICCA Stroke 2018
  • Mar 27, 2018: InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Peru
  • Mar 05, 2018: InspireMD Announces First Patient Treated with CGuardTM EPS in India
  • Feb 26, 2018: Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX AR-V7 Nucleus Detect Test to Predict Treatment Response in Metastatic Disease
  • Feb 23, 2018: NIH Launches International Study of AMD Progression
  • Feb 22, 2018: InspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea
  • Feb 20, 2018: InspireMD Announces Commercial Launch and First Sales of CGuard EPS in India
  • Feb 14, 2018: InspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard EPS Fourth Quarter Sales Increase 211% Versus Same Period Last year
  • Jan 31, 2018: Philips and VPS Healthcare Sign 10-year Agreement for Philips' Enterprise-wide Electronic Medical Record solution
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
  • InspireMD Inc Pipeline Products by Equipment Type
  • InspireMD Inc Pipeline Products by Indication
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
  • InspireMD Inc, Key Facts
  • InspireMD Inc, Major Products and Services
  • InspireMD Inc Number of Pipeline Products by Development Stage
  • InspireMD Inc Pipeline Products Summary by Development Stage
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
  • InspireMD Inc Ongoing Clinical Trials Summary
  • CGuard Embolic Prevention System - Product Status
  • CGuard Embolic Prevention System - Product Description
  • CGuard Embolic Prevention System - Independent Randomized Trial in Carotid Artery Revascularization Comparing the Stent (Acculink) Versus the Mesh Covered Stent (CGuard): The SIBERIA Trial
  • MGuard Drug Eluting Stent - Product Status
  • MGuard Drug Eluting Stent - Product Description
  • MGuard Prime EPS - Product Status
  • MGuard Prime EPS - Product Description
  • MGuard Prime EPS - Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries
  • Next Gen CGuard - 5F - Product Status
  • Next Gen CGuard - 5F - Product Description
  • NGuard Neurovascular - Product Status
  • NGuard Neurovascular - Product Description
  • PVGuard Peripheral - Product Status
  • PVGuard Peripheral - Product Description
  • RGuard Renal - Product Status
  • RGuard Renal - Product Description
  • InspireMD Inc, Key Employees
  • InspireMD Inc, Other Locations
  • InspireMD Inc, Subsidiaries
  • Glossary
List of Figures
  • InspireMD Inc Pipeline Products by Equipment Type
  • InspireMD Inc Pipeline Products by Development Stage
  • InspireMD Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bioiasis AD Sofia
  • Etropal Ad
  • InterCure Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll